References
- Sadovnikoff N., Varon J., Sternbach G. Carbon monoxide poisoning, an occult epidemic. Postgraduate Medicine 1992; 92: 86–95
- Bruno A., Wagner W., Orrison W. Clinical outcome and brain MRI four years after carbon monoxide intoxication. Acta Neurologica Scandinavia 1993; 87: 205–209
- Crocker P., Walker J. Pediatric carbon monoxide toxicity. Journal of Emergency Medicine 1985; 3: 443–448
- Birnder J., Roberts R. Carbon monoxide intoxication in children. Clinical Toxicology 1980; 16: 287–295
- Murata T., Itoh S., Koshino Y. Serial proton magnetic spectroscopy in a patient with the interval form of carbon monoxide poisoning. Journal of Neurology, Neurosurgery, Psychiatry 1995; 58: 100–103
- Norris C., Trench J., Hook R. Delayed carbon monoxide encephalopathy: Clinical and research implications. Journal of Clinical Psychiatry 1982; 43: 294–295
- Folstein M., Folstein S., McHugh P. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12: 189–198
- Cockrell J., Folstein M. Mini-mental state examination (MMSE). Psychopharmacology Bulletin 1988; 24: 689–692
- Litoritz T., Felberg L., White S. Annual report of the American Association of Poison Control Centers toxic exposure surveillance system. American Journal of Emergency Medicine 1995; 145: 487–537, 1996.
- James J., Lagasse J., Zimmerman G. Computed tomographic findings after acute carbon monoxide poisoning. American Journal of Emergency Medicine 1994; 12: 448–451
- Murata T., Koshino Y., Nishio M. Serial proton magnetic resonance spectroscopy in a patient with acute carbon monoxide poisoning. Biologic Psychiatry 1995; 37: 541–545
- Zagami A., Lethleann A., Mellick R. Delayed neurological deterioration following carbon monoxide poisoning: MRI findings. Journal of Neurology 1993; 240: 113–116
- White K., Cummings J. Neuropsychiatric aspects of Alzheimer's disease and other dementing illnesses. Textbook of Neuropsychiatry, S. C. Yudofsky, R. E. Hales. American Psychiatric Press, Inc., Washington, DC 1997; 823–854
- Reut D. A., Perper J. A., Mortiz G. Psychiatric risk factors for adolescent suicide: A case-control study. Journal of American Academy of Child and Adolescent Psychiatry 1993; 32: 521–529
- Huber S., Freidenberg D., Paulson G. The pattern of progressive symptoms varies with progression of Parkinson's disease. Journal of Neurology. Neurosurgery, Psychiatry 1990; 53: 275–278
- Anderson G., Vestergaard K., Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25: 1099–1104
- Jimenez-Jimenez F., Tefeiro J., Martinez-Junquera G. Parkinsonism exacerbated by paroxitine. Neurology 1994; 44: 2406
- Adler L., Angrist B. Paroxitine and akathisia. Biology Psychiatry 1995; 37L: 336–337
- Sternbach H. The serotonin syndrome. American Journal of Psychiatry 1991; 148: 705–713
- Harvey A., Burke M. Comment on the serotonin syndrome associated with paroxitine. American Journal of Emergency Medicine 1995; 13: 605–606
- Nemeroff C. Paroxitine: an overview of the efficacy and safety of a new selective serotinin reuptake inhibitor in the treatment of depression. Journal of Clinical Psychopharmacology 1993; 13: 105–175